Medullary thyroid carcinoma in a child with a new RET mutation and a RET polymorphism

被引:0
作者
Vandenbosch, K
Renard, M
Uyttebroeck, A
Sciot, R
Matthijs, G
Legius, E
机构
[1] Katholieke Univ Leuven Hosp, Ctr Human Genet, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven Hosp, Dept Pathol, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Paediat, B-3000 Louvain, Belgium
来源
GENETIC COUNSELING | 2005年 / 16卷 / 01期
关键词
medullary thyroid carcinoma; multiple endocrine neoplasia type 2; RET;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Medullary thyroid carcinoma in a child with a new RET mutation and a RET polymorphism: We report a 12 year old boy with an isolated medullary thyroid carcinoma (MTC). A mutation analysis of the RET-proto-oncogene in this boy showed an in frame insertion-deletion mutation (insTTCTdelG) at codon 666 of the RET proto-oncogene. This RET mutation has not been reported previously. The boy's mother and his 82-year-old maternal grandfather showed the same mutation. None of the two ever showed symptoms of MTC. The mother underwent a preventive total thyroidectomy and pathological examination showed C-cell hyperplasia and early MTC. Further genetic analysis showed that the boy inherited a well-known coding polymorphism in exon 11 (G691S) from his father. Therefore the boy is a compound heterozygote for the insertion-deletion mutation at codon 666 and the G691S polymorphism in the RET gene. We hypothesize that the insTTCTdelG mutation at codon 666 is associated with low penetrance for MTC and that the young age of MTC in the reported child results most likely from the additive effects of both mutations (insTTCTdelG and G691S).
引用
收藏
页码:95 / 100
页数:6
相关论文
共 14 条
  • [1] Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression
    Borrego, S
    Sáez, ME
    Ruiz, A
    Gimm, O
    López-Alonso, M
    Antiñolo, G
    Eng, C
    [J]. JOURNAL OF MEDICAL GENETICS, 1999, 36 (10) : 771 - 774
  • [2] Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue
    Bounacer, A
    Du Villard, JA
    Wicker, R
    Caillou, B
    Schlumberger, M
    Sarasin, A
    Suárez, HG
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (12) : 1929 - 1936
  • [3] Chan JK, 2000, DIAGNOSTIC HISTOPATH, P959
  • [4] RET proto-oncogene in the development of human cancer
    Eng, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 380 - 393
  • [5] The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis
    Eng, C
    Clayton, D
    Schuffenecker, I
    Lenoir, G
    Cote, G
    Gagel, RF
    vanAmstel, HKP
    Lips, CJM
    Nishisho, I
    Takai, SI
    Marsh, DJ
    Robinson, BG
    FrankRaue, K
    Raue, F
    Xue, FY
    Noll, WW
    Romei, C
    Pacini, F
    Fink, M
    Niederle, B
    Zedenius, J
    Nordenskjold, M
    Komminoth, P
    Hendy, GN
    Gharib, H
    Thibodeau, SN
    Lacroix, A
    Frilling, A
    Ponder, BAJ
    Mulligan, LM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19): : 1575 - 1579
  • [6] Genetic analysis of RET, GFRα1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A
    Gil, L
    Azañedo, M
    Pollán, M
    Cristobal, E
    Arribas, B
    García-Albert, L
    García-Sáiz, A
    Maestro, ML
    Torres, A
    Menárguez, J
    Rojas, JM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (02) : 299 - 304
  • [7] PTC IS A NOVEL REARRANGED FORM OF THE RET PROTO-ONCOGENE AND IS FREQUENTLY DETECTED INVIVO IN HUMAN THYROID PAPILLARY CARCINOMAS
    GRIECO, M
    SANTORO, M
    BERLINGIERI, MT
    MELILLO, RM
    DONGHI, R
    BONGARZONE, I
    PIEROTTI, MA
    DELLAPORTA, G
    FUSCO, A
    VECCHIO, G
    [J]. CELL, 1990, 60 (04) : 557 - 563
  • [8] CHILDHOOD THYROID-CANCER IN ENGLAND AND WALES
    HARACH, HR
    WILLIAMS, ED
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (03) : 777 - 783
  • [9] EXPRESSION OF THE RET PROTOONCOGENE PRODUCT IN HUMAN NORMAL AND NEOPLASTIC TISSUES OF NEURAL CREST ORIGIN
    NAKAMURA, T
    ISHIZAKA, Y
    NAGAO, M
    HARA, M
    ISHIKAWA, T
    [J]. JOURNAL OF PATHOLOGY, 1994, 172 (03) : 255 - 260
  • [10] Perry A, 1996, CANCER-AM CANCER SOC, V77, P750, DOI 10.1002/(SICI)1097-0142(19960215)77:4<750::AID-CNCR22>3.0.CO